The industry-influence watchdogs at the American Medical Student Association gave more U.S. med schools high grades for their conflict-of-interest policies, with two-thirds earning As or Bs, up from 52% last year. But on-campus CME programs and sales-rep visits "remain challenging areas," the AMSA's PharmFree Scorecard notes. Report